The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early ...

Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic ...

The federal grants will support CranioSense’s development and validation of its non-invasive intracranial pressure monitoring ...

Next year will mark a turning point for AI in healthcare as the industry shifts from pilots and hype to accountable, integrated systems that prove to have measurable impact, according to execs.

The partnership comes three months after Thyme Care raised $97 million in funding, bringing its total raise to $275 million.

AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.

The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise ...

The Order says it revokes attempts to paralyze the AI industry and establishes an AI Litigation Task Force to challenge State ...

ADP participated as a new investor in Thatch's $40 million Series B funding round in April, which brought the company's total ...

Tampa General Hospital Cancer Institute will integrate Reimagine's platform into its clinical pathways to reduce workforce ...

Med’s registry platform will work alongside WellSky’s network of home-based care organizations to let patients participate in ...